News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Hull Hans
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/07/2023 |
4
| Hull Hans (Chief Business Officer) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Sold 13,069 shares
@ $20, valued at
$261.4k
Sold 1,800 shares
@ $20, valued at
$36k
Sold 20,050 shares
@ $20.01, valued at
$401.2k
Exercised 1,800 options to buy
@ $2.08, valued at
$3.7k
Exercised 8,791 options to buy
@ $2.08, valued at
$18.3k
|
|
| 08/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2023 |
4
| Hull Hans (Chief Business Officer) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 35,156 shares
@ $0 |
|
| 04/03/2023 |
4
| Hull Hans (Chief Business Officer) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Sold 9,036 shares
@ $26.5209, valued at
$239.6k
|
|
| 03/31/2023 |
4
| Hull Hans (Chief Business Officer) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 17,578 shares
@ $0 |
|
| 01/27/2023 |
4
| Hull Hans (Chief Business Officer) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 54,000 shares
@ $0
Granted 76,200 options to buy
@ $34.65, valued at
$2.6M
|
|
| 12/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2021 |
4
| Hull Hans (Chief Business Officer) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 62,250 options to buy
@ $26.5, valued at
$1.6M
|
|
| 01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2020 |
4
| Hull Hans (Chief Business Officer) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Converted 5,079 shares
@ $0
Converted 3,821 shares
@ $0
Granted 27,322 preferred shares
@ $13.0845, valued at
$357.5k
Granted 70,352 options to buy
@ $0
Converted 36,319 preferred shares
@ $0
Converted 27,322 preferred shares
@ $0 |
|
| 06/02/2020 |
3
| Hull Hans (Chief Business Officer) has filed a Form 3 on PLIANT THERAPEUTICS, INC. |
|
|